Nyrada Inc. (ASX:NYR)
Australia · Delayed Price · Currency is AUD 0.7700
-0.0400 (-4.94%)
Feb 11, 2026, 10:56 AM AEST
Nyrada Market Cap
Nyrada has a market cap or net worth of 198.41 million as of February 10, 2026. Its market cap has increased by 996.87% in one year.
Market Cap
198.41M
Enterprise Value
195.48M
Revenue
2.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.77
Market Cap Chart
Since January 16, 2020, Nyrada's market cap has increased from 25.71M to 198.41M, an increase of 671.87%. That is a compound annual growth rate of 40.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 198.41M | -27.18% |
| Dec 31, 2025 | 272.45M | 1,278.00% |
| Dec 31, 2024 | 19.77M | 476.06% |
| Dec 29, 2023 | 3.43M | -84.83% |
| Dec 30, 2022 | 22.62M | -39.58% |
| Dec 31, 2021 | 37.44M | 42.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dimerix | 294.19M |
| Orthocell | 246.89M |
| Botanix Pharmaceuticals | 236.41M |
| Tetratherix | 187.83M |
| Recce Pharmaceuticals | 164.83M |
| Starpharma Holdings | 155.37M |
| Actinogen Medical | 137.25M |
| Paradigm Biopharmaceuticals | 125.77M |